posted on 5:19 AM, June 25, 2014
Click here for a .pdf of this press release
PRWeb ebooks - Another online visibility tool from PRWeb
The use of Prescription Drug Monitoring Programs (PDMP) by clinicians helps identify
aberrant opioid use patterns in patients. Researchers from the American College of Medical
Toxicology discussed barriers to full utilization of these programs at a nationwide meeting of
Washington, DC (PRWEB) June 19, 2012 -- Misuse of prescription opioids, such as oxycodone (in Percocet)
and hydrocodone (in Vicodin), is associated with epidemic levels of addiction, harm, and death in the US. Since
these drugs are typically acquired through prescribing by healthcare providers, prescription drug monitoring
programs have been developed to help prescribers identify patients who may be misusing, abusing, or diverting
prescription opioid medications for other uses.
Prescription drug monitoring programs are state-based data collection systems that track prescribing and
dispensing of certain federally scheduled medications, including opioids as well as sedatives like alprazolam
(found in Xanax). Most states allow prescribers to access the system prior to prescribing a controlled
medication and review the patient’s prescription history for signs of aberrancy, as this is often a sign of misuse.
Nearly every state (49/50) has or is planning to have such a system, although they vary widely in functionality
and ease of use.
Researchers from the American College of Medical Toxicology, who recently investigated factors that prevent
wider use of these programs, presented their insights gleaned from prescribers’ concerns at the Harold Rogers
Prescription Drug Monitoring ProgramNational Meeting in Washington, DC on June 6, 2012. According to one
of the presenters, Jeanmarie Perrone, M.D., an emergency physician and medical toxicologist from the
University of Pennsylvania, “the group was incredibly interested in the user feedback we provided, and were
eager to discuss improvements in the programs to help promote safe opioid prescribing.”
The major limitation highlighted was the time to use these programs. Coauthor Lewis Nelson, M.D., also an
emergency physician and medical toxicologistfrom New York University, dramatized the typical frustrations of
a busy emergency physician attempting to check the prescription drug monitoring program in a prototypical
patient. According to Dr. Nelson, “the amount of time and effort along with the disappointing results with some
of these systems creates a major barrier to efficiency,” and increases the reluctance to the regular use of these
very important programs.
Although the authors acknowledged that there are limitations, the potential upside of these programs is great,
and they remain optimistic that with enhancement, prescription drug monitoring programs may help to diminish
the magnitude of the prescription drug epidemic.
The same researchers recently published a Perspectives article in the New England Journal of Medicine
highlighting additional aspects of rational opioid prescribing.
The American College of Medical Toxicology (ACMT) is a professional, nonprofit association of physicians
with recognized expertise in medical toxicology. The College is dedicated to advancing the science and practice
of medical toxicology to improve the care of poisoned patients.
If you have any questions regarding information in these press releases please contact the company listed in the press release. Our complete disclaimer
appears here - PRWeb ebooks - Another online visibility tool from PRWeb
American College of Medical Toxicology
Online Web 2.0 Version
You can read the online version of this press release here.